The Biological Significance of Yawning Elicited by Application of Electromagnetic Fields in Multiple Sclerosis

References

• Abrams G. M., Nilaver G., Hoffman D., Zimmerman E. A., Ferin M., Krieger D. T., Liotta A. S. Immunocytochemical distribution of corticotropin (ACTH) in monkey brain. Neurology 1980; 30: 1106–1110
   PubMedGoogle Scholar
• Anderson B. Is alpha-MSH deficiency the cause of Alzheimer's disease?. Medical Hypotheses 1986; 19: 379–385
   PubMed Web of Science ®Google Scholar
• Arai H., Moroji T., Kosaka K., Iizuka R. Extrahypophyseal distribution of alpha-melanocyte stimulating hormone (alpha-MSH)-like immunoreactivity in postmortem brains from normal subjects and Alzheimer-type dementia patients. Brain Research 1986; 377: 305–310
   PubMedGoogle Scholar
• Argiolas A., Gessa G. L. Oxytocin: a powerful stimulant of penile erection and yawning in male rats. Hypothalamic dysfunction in neuropsychiatric disorders, D. Nerozzi, F. K. Goodwin, E. Costa. Raven Press, New York 1987; 153–163
   Google Scholar
• Barasi S., Roberts M. H. T. The action of 5-hydroxytryptamine antagonists and precursors on bulbospinal facilitation of spinal reflexes. Brain Research 1973; 52: 385–388
   PubMed Web of Science ®Google Scholar
• Baumgarten H. G., Lachenmayer L. Anatomical features and physiological properties of central serotonin neurons. Pharmacopsychiatrie 1985; 18: 180–187
   PubMed Web of Science ®Google Scholar
• Bawin S. M., Adey W. R. Sensitivity of calcium binding in cerebral tissue to weak environmental electric fields oscillating at low frequency. Proceedings of the National Academy of Sciences, USA 1976; 73: 1999–2003
   PubMed Web of Science ®Google Scholar
• Berardi A., Rainero I., Kaye J. A., May C., Haxby J. V., Grady C. L., Rapoport S. I. Concentration of cerebrospinal fluid alpha-melanocyte stimulating hormone correlates with nonverbal-visual performance in dementia of the Alzheimer type. Annals of Neurology 1988; 24: 159
   Web of Science ®Google Scholar
• Bertolini A., Gessa G. L. Behavioral effects of ACTH and MSH peptides. Journal of Endocrine Investigation 1981; 4: 241–251
   PubMed Web of Science ®Google Scholar
• Bijlsma W. A., Van Asselt E., Veldman H., Jennekens F. G. I., Schotman P., Gispen W. H. Ultrastructural study of effect of ACTH (4–10) on nerve regeneration: axons become larger in number and smaller in diameter. Acta Neuropathologica 1983; 62: 24–30
   PubMed Web of Science ®Google Scholar
• Blackmail C. F. Stimulation of brain tissue in vitro by extremely low frequency, low intensity, sinusoidal electromagnetic fields. Electromagnetic fields and neurobehavioral function, M. E. O'Connor, R. H. Lovely. Alan R. Liss, New York 1988
   Google Scholar
• Boshes B. Syndromes of the diencephalon. Handbook of clinical neurology: localization in clinical neurology, P. J. Vinken, G. W. Bruyn. Elsevier, Amsterdam 1969; vol. 2: 450
   Google Scholar
• Botticelli L. J., Wurtman R. J. Corticotropin regulates transynaptically the activity of sep-tohippocampal cholinergic neurones. Nature 1981; 289: 75–76
   PubMedGoogle Scholar
• Caine E. D., Bamford H. A., Schiffer R. B., Shoulson I., Levy S. A controlled neuropsychological comparison of Huntington's disease and multiple sclerosis. Archives of Neurology 1986; 43: 249–254
   PubMed Web of Science ®Google Scholar
• Claveria L. E., Curzon G., Harrison M. J. G., Kantamaneni B. D. Amine metabolites in the cerebrospinal fluid of patients with disseminated sclerosis. Journal of Neurology, Ncurosurgery' and Psychiatry 1974; 37: 715–718
   PubMed Web of Science ®Google Scholar
• Cooper S. J., Rusk I. N., Barber D. J. Yawning induced by the selective dopamine D2 agonist N-0437 is blocked by the selective dopamine autoreceptor antagonist (+)-UH 232. Physiology & Behavior 1989; 45: 1263–1266
   PubMed Web of Science ®Google Scholar
• Davidson D., Pullar I. A., Mawdsley C, Kinloch N., Yates C. M. Monoamine metabolites in cerebrospinal fluid in multiple sclerosis. Journal of Neurology. Neurosurgery, and Psychiatry 1977; 40: 741–745
   PubMed Web of Science ®Google Scholar
• DeJong R. N. The neurologic examination. Harper & Row, Philadelphia 1979; 237
   Google Scholar
• Erlich S. S., Apuzzo M. L. J. The pineal gland: anatomy, physiology, and clinical significance. Journal of Neurosurgery 1985; 63: 321–341
   PubMed Web of Science ®Google Scholar
• Facchinetti F., Nappi G., Petraglia F., Martignoni E., Sinforiani E., Genazzani A. R. Central ACTH deficit in degenerative and vascular dementia. Life Sciences 1984; 35: 1691–1697
   PubMedGoogle Scholar
• Ferrari W. Behavioral changes in animals after intracisternal injection with adreno-corticotrophic hormone and melanocyte stimulating hormone. Nature 1958; 181: 925–926
   PubMedGoogle Scholar
• Ferrari W., Gessa G. L., Vargiu L. Behavioral effects induced by intracisternally injected ACTH and MSH. Annals of the New York Academy of Sciences 1963; 104: 330–345
   PubMed Web of Science ®Google Scholar
• Filley C. M., Heaton R. K., Nelson L. M., Burks J. S., Franklin G. M. A comparison of dementia in Alzheimer's disease and multiple sclerosis. Archives of Neurology 1989; 46: 157–161
   PubMedGoogle Scholar
• Gessa G. L., Pisano M., Vargiu L., Carbai F., Ferrari W. Stretching and yawning movements after intracerebral injection of ACTH. Revue Canadienue Biologigue 1967; 26: 229–236
   PubMedGoogle Scholar
• Gilad G., Mahon B. D., Finkelstein Y., Koffler B., Gilad V. H. Stress-induced activation of the hippocampal cholinergic system and the pituitary-adrenocortical axis. Brain Research 1985; 347: 404–408
   PubMedGoogle Scholar
• Gispen W. H., Isaacson R. L., Spruijt B. M., De Wied D. Melanocortins, neural plasticity and aging. Progress in Neuropsychopharmacology & Biological Psychiatry 1986; 10: 415–426
   PubMedGoogle Scholar
• Jacobs B. L. Serotonin and behavior: emphasis on motor control. Journal of Clinical Psychiatry 1991; 52(12. Suppl)17–23
   PubMed Web of Science ®Google Scholar
• Jacobs B. L. Serotonin, motor activity ad depression-related disorders. American Scientist 1994; 82: 456–463
   Web of Science ®Google Scholar
• Jacobs B. L., Fornal C. A. 5-HT and motor control: a hypothesis. Trends in Neurosciences 1993; 16: 346–352
   PubMed Web of Science ®Google Scholar
• Jaffe R. A., Laszcwski B. L., Carr D. B., Phillips R. D. Chronic exposure to a 60-Hz electric field: effects on synaptic transmission and peripheral nerve function in the rat. Bioelectromagnetics 1980; 1: 131–147
   PubMedGoogle Scholar
• Jacquet Y. F., Abrams G. M. Postural asymmetry and movement disorder after unilateral microinjection of adrenocorticotropin (1–24) in rat brainstem. Science 1982; 218: 175–177
   PubMed Web of Science ®Google Scholar
• Kleber G. I., Gramsch C., Holli V., Mehraein P., Pasi A., Herz A. Extrahypothalamic corticotropin and alpha-melanotropin in human brain. Neuroendocrinology 1980; 31: 39–45
   PubMedGoogle Scholar
• Maestroni G. J. M. The immunoneuroendocrine role of melatonin. Journal of Pineal Research 1993; 14: 1–10
   PubMed Web of Science ®Google Scholar
• Maestroni G. J. M., Conti A., Pierpaoli W. Melatonin counteracts the effect of acute stress on the immune system via an opiatergic system. Fundamentals and clinics in pineal research, G. P. Trentini, C. De Gaetani, P. Pevet. Raven Press, New York 1987; vol. 44: 277–279
   Google Scholar
• Miller L. H., Kastin A. J., Sandman C. A., Fink M., VanVeen W. J. Polypeptide influence on attention, memory, and anxiety in man. Pharmacology Biochemistry and Behavior 1978; 2: 663–668
   Google Scholar
• Mogilnicka E., Kilmer V. Drugs affecting dopamine neurones and yawning behaviour. Pharmacology Biochemistry and Behavior 1977; 7: 303–305
   PubMed Web of Science ®Google Scholar
• Mogilnicka E., Boissard C. G., Delini-Stula A. Effects of apomorphine, TL-99 and 3-PPP on yawning in rats. Neuropharmacology 1984; 23: 19–22
   PubMed Web of Science ®Google Scholar
• O'Donohue T. L., Dorsa D. M. The Opiomelanotrophinergic neuronal and endocrine systems. Peptides 1982; 3: 353–395
   PubMed Web of Science ®Google Scholar
• Rainero I., May M. D., Kaye J. A., Friedland R. P., Rapoport S. I. CSF alpha-MSH in dementia of the Alzheimer type. Neurology 1988; 38: 1281–1284
   PubMed Web of Science ®Google Scholar
• Rollinson R. D., Wiggins W. S., Gilligan B. S. Drug-induced yawning successfully treated with pimozine. Archives of Neurology 1979; 36: 253
   Google Scholar
• Rusovan A., Kanje M. D600, a Ca++ antagonist, prevents stimulation of nerve regeneration by magnetic fields. NeuroReport 1992; 3: 813–814
   PubMed Web of Science ®Google Scholar
• Sandyk R. Successful treatment of multiple sclerosis with magnetic fields. International Journal of Neuroscience 1992; 66: 237–250
   PubMed Web of Science ®Google Scholar
• Sandyk R. Demyelination as an epiphenomenon in multiple sclerosis. International Journal of Neuroscience 1993; 72: 141–148
   PubMedGoogle Scholar
• Sandyk R. Rapid normalization of visual evoked potentials by picotesla range magnetic fields in chronic progressive multiple sclerosis. International Journal of Neuroscience 1994a; 77: 243–259
   PubMed Web of Science ®Google Scholar
• Sandyk R. Further observations on the effects of external picotesla range magnetic fields on visual memory and visuospatial functions in multiple sclerosis. International Journal of Neuroscience 1994b; 11: 203–227
   Google Scholar
• Sandyk R. Chronic relapsing multiple sclerosis: A case of rapid recovery by application of weak electromagnetic fields. International Journal of Neuroscience 1995a; 82: 223–242
   PubMed Web of Science ®Google Scholar
• Sandyk R. Cholinergic mechanisms in Gilles de la Tourette's syndrome. International Journal of Neuroscience 1995b; 81: 95–100
   PubMedGoogle Scholar
• Sandyk R. Treatment with electromagnetic fields alters the clinical course of chronic progressive multiple sclerosis- A case report. International Journal ofNeuroscience
   Web of Science ®Google Scholar
• Sandyk R., Awerbuch G. I. Nocturnal plasma melatonin and alpha-melanocyte stimulating hormone levels during exacerbation of multiple sclerosis. International Journal of Neuroscience 1992; 67: 173–186
   PubMed Web of Science ®Google Scholar
• Sandyk R., Awerbuch G. I. Nocturnal melatonin secretion in multiple sclerosis patients with affective disorders. International Journal of Neuroscience 1993; 68: 227–240
   PubMed Web of Science ®Google Scholar
• Sandyk R., Dann L. C. Weak electromagnetic fields attenuate tremor in multiple sclerosis. International Journal of Neuroscience 1994; 79: 199–212
   PubMed Web of Science ®Google Scholar
• Sandyk R., Dann L. C. Resolution of Lhermitte's sign in multiple sclerosis by treatment with weak electromagnetic fields. International Journal of Neuroscience 1995; 81: 215–224
   PubMed Web of Science ®Google Scholar
• Sandyk R., Derpapas K. Magnetic fields normalize visual and brainstem auditory evoked potentials in multiple sclerosis. International Journal of Neuroscience 1993a; 68: 241–253
   PubMedGoogle Scholar
• Sandyk R., Derpapas K. Successful treatment of an acute exacerbation of multiple sclerosis by external magnetic fields. International Journal ofNeuroscience 1993b; 70: 97–105
   PubMedGoogle Scholar
• Sandyk R., Iacono R. P. Resolution of longstanding symptoms of multiple sclerosis by application of picotesla range magnetic fields. International Journal of Neuroscience 1993; 70: 255–269
   PubMed Web of Science ®Google Scholar
• Sandyk R., Iacono R. P. Improvement by picotesla magnetic fields of perceptual-motor performance in a patient with chronic progressive multiple sclerosis. International Journal of Neuroscience 1994a; 78: 53–66
   PubMed Web of Science ®Google Scholar
• Sandyk R., Iacono R. P. Multiple sclerosis: Improvement of visuoperceptive functions by picotesla range magnetic fields. International Journal of Neuroscience 1994b; 74: 177–189
   PubMedGoogle Scholar
• Semm P. Pineal function in mammals and birds is altered by earth-strength magnetic fields. Electromagnetic fields and circadian rhythmicity, M. C. Moore-Ede, S. S. Campbell, R. J. Reiter. Birkhauser, Boston 1992; 53–62
   Google Scholar
• Serra G., Collu M., Gessa G. L. Dopamine receptors mediating yawning: are they autorceptors?. European Journal of Pharmacology 1986; 120: 187–192
   PubMed Web of Science ®Google Scholar
• Sonninen V., Riekkinen P., Rinne U. K. Acid monoamine metabolites in cerebrospinal fluid in multiple sclerosis. Neurology 1973; 23: 760–763
   PubMed Web of Science ®Google Scholar
• Strand F. L., Cayer A. A modulatory effect of pituitary polypeptides on peripheral nerve and muscle. Progress in Brain Research 1975; 42: 187–194
   PubMedGoogle Scholar
• Strand F. L., Stoboy H., Cayer A. A possible direct action of ACTH on nerve and muscle. Neuroenclocrinology 1973; 13: 1–20
   PubMedGoogle Scholar
• Szechtman H., Cleghom J. M., Brown G. M., Kaplan R. D., Franco S., Rosenthal K. Sensitization and tolerance to apomorphine in men: yawning, growth hormone, nausea and hyperthermia. Psxchiatry Research 1988; 23: 245–255
   PubMed Web of Science ®Google Scholar
• Tonnaer J. A. D. M., Van Vugt M., De Graaf J. S. In vitro interaction of ACTH with rat brain muscarinic receptors. Peptides 1986; 7: 425–429
   PubMedGoogle Scholar
• Urba-Holmgren R., Gonzales R. M., Holmgren B. Is yawning a cholinergic response?. Nature 1977; 267: 261–262
   PubMed Web of Science ®Google Scholar
• Urba-Holmgren R., Holmgren B., Rodriguez R., Gonzalez R. M. Serotonergic modulation of yawning. Pharmacology Biochemistry & Behavior 1979; 11: 371–372
   PubMedGoogle Scholar
• Welker H. A., Semm P., Willie R. P., Commemz J. C., Wiltschko W., Vollrath L. Effects of an artificial magnetic field on serotonin N-acetyltransferase activity and melatonin content of the rat pineal gland. Experimental Brain Research 1983; 50: 426–432
   PubMed Web of Science ®Google Scholar
• Wood P. L., Malthe-Sorenssen D., Cheney D. L., Costa E. Increase of hippocampal acetylcholine turnover rate and the stretching-yawning syndrome elicited by alpha-MSH and ACTH. Life Sciences 1978; 22: 673–678
   PubMed Web of Science ®Google Scholar